<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01990482</url>
  </required_header>
  <id_info>
    <org_study_id>gungorduk15</org_study_id>
    <nct_id>NCT01990482</nct_id>
  </id_info>
  <brief_title>Influence of Coffee Intake on Postoperative Bowel Function After Comprehensive Staging Surgery for Gynecological Malignancies: A Randomized Controlled Trial.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erzincan Military Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erzincan Military Hospital</source>
  <brief_summary>
    <textblock>
      A delay in the return of normal bowel function with the passage of flatus and feces is one of
      the most important factors affecting early recovery and discharge in patients undergoing open
      complete staging surgery for gynecological malignancies. A prolonged hospital stay increases
      the risk of hospital-acquired infections, deep vein thrombosis, pulmonary compromise and
      total hospital costs.

      The aim of this study was to assess the effectiveness of coffee intake on postoperative bowel
      function in patients undergoing abdominal complete staging surgery for gynecological
      malignancies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to first flatus</measure>
    <time_frame>within the first 30 days after surgery</time_frame>
    <description>hours from end of operation to first flatus pass time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to tolerance diet</measure>
    <time_frame>within the first 30 days after surgery</time_frame>
    <description>time to end of the surgery until the first solid diet intake without vomiting</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">118</enrollment>
  <condition>Ilues</condition>
  <arm_group>
    <arm_group_label>coffee</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>coffee</description>
  </arm_group>
  <arm_group>
    <arm_group_label>water group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>water</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>caffe</intervention_name>
    <arm_group_label>coffee</arm_group_label>
    <arm_group_label>water group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Water</intervention_name>
    <arm_group_label>coffee</arm_group_label>
    <arm_group_label>water group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients preparing for complete surgical staging for malignant gynecologic
             disease such as endometrial cancer, cervix cancer and ovarian cancerwere assessed for
             eligibility. Exclusion Criteria: Exclusion criteria for the study

          -  included thyroid diseases,

          -  inflammatory bowel disease,

          -  complaints of chronic constipation (defined as two or fewer bowel movements per week),

          -  a history of prior abdominal bowel surgery, abdominal radiation, neoadjuvant
             chemotherapy,

          -  need for intensive care more that 24 hpostoperatively,

          -  nasogastric tube drainage beyond the first postoperative morning,

          -  bowel anastomosis and upper abdominalmultivisceral surgical approaches in relation to
             the debulking surgery.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Tepecik Education Research Hospital</name>
      <address>
        <city>Izmir</city>
        <state>Tepecik</state>
        <zip>35600</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2013</study_first_submitted>
  <study_first_submitted_qc>November 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2013</study_first_posted>
  <last_update_submitted>April 21, 2016</last_update_submitted>
  <last_update_submitted_qc>April 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erzincan Military Hospital</investigator_affiliation>
    <investigator_full_name>Kemal GUNGORDUK</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

